AU2008304019A1 - Phage Phi-mru polynucleotides and polypeptides and uses thereof - Google Patents

Phage Phi-mru polynucleotides and polypeptides and uses thereof Download PDF

Info

Publication number
AU2008304019A1
AU2008304019A1 AU2008304019A AU2008304019A AU2008304019A1 AU 2008304019 A1 AU2008304019 A1 AU 2008304019A1 AU 2008304019 A AU2008304019 A AU 2008304019A AU 2008304019 A AU2008304019 A AU 2008304019A AU 2008304019 A1 AU2008304019 A1 AU 2008304019A1
Authority
AU
Australia
Prior art keywords
polypeptide
phage
cell
seq
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008304019A
Other languages
English (en)
Inventor
Eric Heinz Altermann
Graeme Trevor Attwood
Debjit Dey
William John Kelly
Zhanhao Kong
Sinead Christine Leahy
Dong Li
Christina Diane Moon
Hendricus Janssen Petrus
Robert Starr Ronimus
Carrie Sang
Linley Rose Schofield
Catherine Mary Tootill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pastoral Greenhouse Research Ltd
Original Assignee
Pastoral Greenhouse Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pastoral Greenhouse Research Ltd filed Critical Pastoral Greenhouse Research Ltd
Publication of AU2008304019A1 publication Critical patent/AU2008304019A1/en
Priority to AU2014210647A priority Critical patent/AU2014210647B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/13—Tumour cells, irrespective of tissue of origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
    • Y02P60/20—Reduction of greenhouse gas [GHG] emissions in agriculture, e.g. CO2
    • Y02P60/22—Methane [CH4], e.g. from rice paddies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
AU2008304019A 2007-09-25 2008-09-25 Phage Phi-mru polynucleotides and polypeptides and uses thereof Abandoned AU2008304019A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2014210647A AU2014210647B2 (en) 2007-09-25 2014-08-08 Phage phimru polynucleotides and polypeptides and uses thereof

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US97510407P 2007-09-25 2007-09-25
US60/975,104 2007-09-25
US98984107P 2007-11-22 2007-11-22
US98984007P 2007-11-22 2007-11-22
US60/989,841 2007-11-22
US60/989,840 2007-11-22
PCT/NZ2008/000248 WO2009041831A1 (en) 2007-09-25 2008-09-25 PHAGE ϕ-MRU POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2014210647A Division AU2014210647B2 (en) 2007-09-25 2014-08-08 Phage phimru polynucleotides and polypeptides and uses thereof

Publications (1)

Publication Number Publication Date
AU2008304019A1 true AU2008304019A1 (en) 2009-04-02

Family

ID=40511642

Family Applications (4)

Application Number Title Priority Date Filing Date
AU2008304019A Abandoned AU2008304019A1 (en) 2007-09-25 2008-09-25 Phage Phi-mru polynucleotides and polypeptides and uses thereof
AU2008304018A Abandoned AU2008304018A1 (en) 2007-09-25 2008-09-25 Cell-permeabilising peptides and polypeptides for microbial cells
AU2008305846A Abandoned AU2008305846A1 (en) 2007-09-25 2008-09-25 Vaccines and vaccine components for inhibition of microbial cells
AU2014210649A Active AU2014210649B2 (en) 2007-09-25 2014-08-08 Cell-permeabilising peptides and polypeptides for microbial cells

Family Applications After (3)

Application Number Title Priority Date Filing Date
AU2008304018A Abandoned AU2008304018A1 (en) 2007-09-25 2008-09-25 Cell-permeabilising peptides and polypeptides for microbial cells
AU2008305846A Abandoned AU2008305846A1 (en) 2007-09-25 2008-09-25 Vaccines and vaccine components for inhibition of microbial cells
AU2014210649A Active AU2014210649B2 (en) 2007-09-25 2014-08-08 Cell-permeabilising peptides and polypeptides for microbial cells

Country Status (17)

Country Link
US (7) US9296789B2 (https=)
EP (5) EP2203467B1 (https=)
JP (5) JP5552053B2 (https=)
CN (4) CN107129524B (https=)
AR (3) AR068552A1 (https=)
AU (4) AU2008304019A1 (https=)
BR (5) BRPI0817299A8 (https=)
CA (3) CA2700162C (https=)
CL (3) CL2008002859A1 (https=)
DK (3) DK2203467T3 (https=)
ES (3) ES2895908T3 (https=)
MX (3) MX2010003328A (https=)
NZ (1) NZ745324A (https=)
RU (1) RU2528854C2 (https=)
UY (3) UY31360A1 (https=)
WO (3) WO2009041831A1 (https=)
ZA (1) ZA201001933B (https=)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107129524B (zh) 2007-09-25 2023-11-21 田园温室气体研究有限公司 用于抑制微生物细胞的疫苗和疫苗组分
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
PL2445515T3 (pl) * 2009-06-26 2016-10-31 Środki przeciwdrobnoustrojowe
AU2010264659B2 (en) * 2009-06-26 2016-08-04 Lysando Aktiengesellschaft Antimicrobial agents
AR077992A1 (es) * 2009-08-27 2011-10-05 Pastoral Greenhouse Gas Res Ltd Secuencia del genoma completo del metanogeno methanobrevibacter ruminantium
SG184836A1 (en) * 2010-04-27 2012-11-29 Lysando Ag Method of reducing biofilms
WO2014046478A1 (ko) * 2012-09-19 2014-03-27 주식회사 카엘젬백스 세포 투과성 펩티드, 그를 포함한 컨쥬게이트 및 그를 포함한 조성물
AU2013359262C1 (en) * 2012-12-12 2021-05-13 Massachusetts Institute Of Technology CRISPR-Cas component systems, methods and compositions for sequence manipulation
AU2014227653B2 (en) 2013-03-15 2017-04-20 The General Hospital Corporation Using RNA-guided foki nucleases (RFNs) to increase specificity for RNA-guided genome editing
US10760064B2 (en) 2013-03-15 2020-09-01 The General Hospital Corporation RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
WO2014204578A1 (en) 2013-06-21 2014-12-24 The General Hospital Corporation Using rna-guided foki nucleases (rfns) to increase specificity for rna-guided genome editing
AU2014346559B2 (en) 2013-11-07 2020-07-09 Editas Medicine,Inc. CRISPR-related methods and compositions with governing gRNAs
CN107406838A (zh) * 2014-11-06 2017-11-28 纳幕尔杜邦公司 Rna引导的内切核酸酶向细胞中的肽介导的递送
CN104789675A (zh) * 2015-04-15 2015-07-22 江苏师范大学 一种检测荷斯坦奶牛瘤胃微生物的方法
EP3292219B9 (en) * 2015-05-04 2022-05-18 Ramot at Tel-Aviv University Ltd. Methods and kits for fragmenting dna
US9512446B1 (en) 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
US9926546B2 (en) 2015-08-28 2018-03-27 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
CN109477065A (zh) * 2016-07-14 2019-03-15 巴斯夫欧洲公司 包含螯合剂的发酵培养基
AU2017386533B2 (en) * 2016-12-29 2024-05-09 Illumina, Inc. Analysis system for orthogonal access to and tagging of biomolecules in cellular compartments
US12473535B2 (en) 2017-01-05 2025-11-18 Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Method for preparing reticulocyte simulating particles and platelet simulating particles, and reference control
US10745439B2 (en) * 2017-03-20 2020-08-18 Regents Of The University Of Minnesota Kinase substrates and methods of use thereof
WO2019147743A1 (en) 2018-01-26 2019-08-01 Massachusetts Institute Of Technology Structure-guided chemical modification of guide rna and its applications
CN111885915B (zh) * 2018-03-19 2023-04-28 瑞泽恩制药公司 使用crispr/cas系统对动物进行转录调制
EP3880698A4 (en) 2018-11-14 2022-11-30 RubrYc Therapeutics, Inc. MANIPULATED CD25 POLYPEPTIDES AND USES THEREOF
CA3120096A1 (en) 2018-11-14 2020-05-22 Rubryc Therapeutics, Inc. Cd25 antibodies
CN109627301B (zh) * 2019-02-18 2022-08-05 浙江新银象生物工程有限公司 Nisin固体稳定剂开发及应用
CA3171721A1 (en) * 2020-03-19 2021-09-23 Fritz Eichenseher A stabilized protein of interest
WO2021207687A1 (en) * 2020-04-10 2021-10-14 Liberty Biosecurity Llc Polypeptide compositions and uses thereof
CN112143747B (zh) * 2020-09-09 2022-09-13 昆明理工大学 一种噬菌体裂解酶及其基因、基因重组表达载体与应用
EP4477215A3 (en) 2020-12-08 2025-02-19 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals
CN112961217B (zh) * 2021-03-19 2022-11-08 江苏元本生物科技有限公司 一种靶向Siglec-15的噬菌体多肽
CN113121705B (zh) * 2021-04-19 2023-03-24 成都英普博集生物科技有限公司 用于制备短肽混合物的融合蛋白、目的多肽、短肽混合物的制备方法及应用
US20240009291A1 (en) * 2022-07-11 2024-01-11 Arkea Bio Corp. Compositions and methods for reducing methane emissions in ruminant populations
CN115417927A (zh) * 2022-09-08 2022-12-02 南京松天盛科生物科技有限公司 小鼠腹水致敏物及其应用
CN120225671A (zh) * 2022-11-03 2025-06-27 螺旋纳米技术公司 瘤胃和产甲烷菌疫苗及其用途
CN115938486B (zh) * 2022-12-06 2023-11-10 内蒙古农业大学 基于图神经网络的抗菌性乳酸菌株筛选方法
WO2025207521A1 (en) * 2024-03-25 2025-10-02 Silage Labs, Inc. Bacteria expressing lysins for inhibition of methanogenesis
WO2025219570A1 (en) 2024-04-17 2025-10-23 Johannes Kepler Universität Linz Composition for inhibiting protein translocation and methods using the same
WO2025233675A1 (en) * 2024-05-10 2025-11-13 Institut Pasteur Use of talosaminidase to regulate populations of archaeal methanogens in industrial, agricultural and medical settings
CN120249257A (zh) * 2025-05-08 2025-07-04 浙江大学 与PeiR裂解酶具有相同蛋白家族注释的产甲烷菌裂解酶及其应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US159861A (en) * 1875-02-16 Improvement in brooms
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
EP0150186A1 (fr) * 1983-05-03 1985-08-07 S.S.M. International Chemical Company Limited Composition a activite pharmaceutique amelioree et utilisation decelle-ci pour des usages veterinaires
GB8815968D0 (en) * 1988-07-05 1988-08-10 Pfizer Ltd Veterinary devices
JPH05219927A (ja) * 1992-02-14 1993-08-31 Gumma Pref Gov 飼料の混合装置及び混合飼料の製造方法
JP3651915B2 (ja) * 1993-06-30 2005-05-25 財団法人神奈川科学技術アカデミー シグナル配列ペプチドをコードするｄｎａ断片の探索法及びそのためのベクター
ZA948204B (en) 1993-10-19 1995-06-12 Commw Scient Ind Res Org Method for improving utilisation of nutrients by ruminant or ruminant-like animals
JPH09507121A (ja) 1993-10-26 1997-07-22 アフィマックス テクノロジーズ ナームロゼ ベノートスハップ 生物学的チップ上の核酸プローブアレー
JPH09508117A (ja) 1994-01-20 1997-08-19 ニュージーランド パストラル アグリカルチャー リサーチ インスティテュート リミティド 反芻動物に有益な物質を投与するための器具
NZ278977A (en) 1994-01-20 1997-03-24 Pastoral Agric Res Inst Nz Ltd Sustained release bolus for ruminants
US6015880A (en) 1994-03-16 2000-01-18 California Institute Of Technology Method and substrate for performing multiple sequential reactions on a matrix
AUPN353695A0 (en) 1995-06-14 1995-07-06 Commonwealth Scientific And Industrial Research Organisation Immunogenic preparation and method for improving the productivity of ruminant animals
WO1998007830A2 (en) * 1996-08-22 1998-02-26 The Institute For Genomic Research COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII)
US5985907A (en) * 1998-08-12 1999-11-16 Health Research, Inc. Method for inhibiting growth of methanogens
AU2002306849A1 (en) 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
AU2002326949A1 (en) 2001-09-18 2003-05-12 The Board Of Regents Of The University Of Nebraska Method for the inhibition of methanogenesis
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
AU2003222249A1 (en) * 2002-03-04 2003-09-22 Fidelity Systems, Inc., Et Al. The complete genome and protein sequence of the hyperthermophile methanopyrus kandleri av19 and monophyly of archael methanogens and methods of use thereof
SE523209C2 (sv) * 2002-05-14 2004-04-06 Akzo Nobel Nv Förfarande för att reducera metanbildningen från matspjälkningsaktiviteter hos djur
WO2006102350A1 (en) 2005-03-23 2006-09-28 Washington University In St. Louis The use of archaea to modulate the nutrient harvesting functions of the gastrointestinal microbiota
CN107129524B (zh) * 2007-09-25 2023-11-21 田园温室气体研究有限公司 用于抑制微生物细胞的疫苗和疫苗组分
CN101434924A (zh) * 2008-12-17 2009-05-20 中南大学 一种分离严格厌氧产甲烷古菌的方法
AR077992A1 (es) * 2009-08-27 2011-10-05 Pastoral Greenhouse Gas Res Ltd Secuencia del genoma completo del metanogeno methanobrevibacter ruminantium
CN101864362B (zh) * 2010-05-19 2012-05-09 江苏加德绿色能源有限公司 一种复合微生物菌剂及其应用
DE102011119230B4 (de) * 2011-11-23 2013-07-11 Audi Ag Kraftwagen-Blinkleuchte und Verfahren zum Betreiben einer Blinkleuchte
US20160002672A1 (en) * 2012-12-21 2016-01-07 Danisco Us Inc. Production of isoprene, isoprenoid, and isoprenoid precursors using an alternative lower mevalonate pathway

Also Published As

Publication number Publication date
EP2203466A4 (en) 2011-04-13
AU2014210649B2 (en) 2016-09-08
EP2203470A4 (en) 2011-04-13
WO2009041832A9 (en) 2009-10-22
EP2203466B1 (en) 2016-04-06
US8586709B2 (en) 2013-11-19
UY31359A1 (es) 2009-04-30
AR068552A1 (es) 2009-11-18
RU2528854C2 (ru) 2014-09-20
EP2203470A2 (en) 2010-07-07
EP3936516A1 (en) 2022-01-12
US20210332087A1 (en) 2021-10-28
CL2008002860A1 (es) 2009-06-05
MX2010003321A (es) 2010-08-03
BRPI0817299A8 (pt) 2019-01-29
ES2587595T3 (es) 2016-10-25
JP2010539926A (ja) 2010-12-24
CL2008002861A1 (es) 2009-03-06
UY31361A1 (es) 2009-04-30
US20100221185A1 (en) 2010-09-02
WO2009041832A3 (en) 2009-06-11
US9296789B2 (en) 2016-03-29
US20100209998A1 (en) 2010-08-19
EP2203466A2 (en) 2010-07-07
BRPI0817312A2 (pt) 2015-03-17
JP2015042166A (ja) 2015-03-05
CN101932595B (zh) 2016-02-10
EP2203467A4 (en) 2011-04-13
NZ745324A (en) 2023-02-24
WO2009041831A1 (en) 2009-04-02
AR068553A1 (es) 2009-11-18
DK2203467T3 (en) 2017-03-27
JP6067209B2 (ja) 2017-01-25
ES2625144T3 (es) 2017-07-18
CA2700162C (en) 2018-08-14
MX2010003319A (es) 2010-09-10
CN101918431B (zh) 2014-10-08
EP3327030B1 (en) 2021-07-21
CL2008002859A1 (es) 2009-03-06
CN102015755A (zh) 2011-04-13
EP2203467B1 (en) 2016-12-14
ES2895908T3 (es) 2022-02-23
JP2017046704A (ja) 2017-03-09
CA2700164A1 (en) 2009-04-02
NZ780936A (en) 2024-08-30
CA2700129A1 (en) 2009-04-02
BRPI0817312B1 (pt) 2018-05-29
WO2009041830A9 (en) 2009-08-27
MX2010003328A (es) 2010-08-16
JP2010539928A (ja) 2010-12-24
BRPI0817299A2 (pt) 2015-06-16
AU2014210649A1 (en) 2014-09-04
AU2008305846A1 (en) 2009-04-02
CA2700162A1 (en) 2009-04-02
AU2008304018A1 (en) 2009-04-02
BR122021010729B1 (pt) 2022-02-15
JP5552053B2 (ja) 2014-07-16
BR122021010737B1 (pt) 2021-09-21
US10995120B2 (en) 2021-05-04
WO2009041831A9 (en) 2009-11-05
CN107129524B (zh) 2023-11-21
DK3327030T3 (da) 2021-10-04
UY31360A1 (es) 2009-04-30
CA2700164C (en) 2018-05-29
CA2700129C (en) 2021-07-20
AR068551A1 (es) 2009-11-18
CN107129524A (zh) 2017-09-05
US20140220636A1 (en) 2014-08-07
CN101932595A (zh) 2010-12-29
JP2010539927A (ja) 2010-12-24
US11926647B2 (en) 2024-03-12
EP3327030A1 (en) 2018-05-30
US20100209999A1 (en) 2010-08-19
WO2009041830A3 (en) 2009-07-02
EP2203467A1 (en) 2010-07-07
US8592556B2 (en) 2013-11-26
ZA201001933B (en) 2013-10-30
RU2010116163A (ru) 2011-11-10
US10590170B2 (en) 2020-03-17
WO2009041830A2 (en) 2009-04-02
WO2009041832A2 (en) 2009-04-02
CN101918431A (zh) 2010-12-15
BR122020023381B1 (pt) 2021-09-08
MX340736B (es) 2016-07-22
US20170342112A1 (en) 2017-11-30
JP5558356B2 (ja) 2014-07-23
DK2203466T3 (en) 2016-07-25
US20200325180A1 (en) 2020-10-15

Similar Documents

Publication Publication Date Title
EP2203467B1 (en) Phage -mru polynucleotides and polypeptides and uses thereof
RU2520738C2 (ru) ПОЛИНУКЛЕОТИДЫ И ПОЛИПЕПТИДЫ ФАГА φ-mru, И ИХ ПРИМЕНЕНИЕ
AU2014210647A1 (en) Phage phimru polynucleotides and polypeptides and uses thereof
Class et al. Patent application title: PHAGE &phgr; MRU POLYNUCLEOTIDES AND POLYPEPTIDES AND USES THEREOF
AU2014213519B2 (en) Vaccines and vaccine components for inhibition of microbial cells
AU2019203617A1 (en) Vaccines and vaccine components for inhibition of microbial cells

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ PHAGE PHI-MRU POLYNUCLEOTIDES ANDPOLYPEPTIDES AND USES THEREOF

MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted